These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31317486)

  • 21. Thrombotic microangiopathy, cancer, and cancer drugs.
    Izzedine H; Perazella MA
    Am J Kidney Dis; 2015 Nov; 66(5):857-68. PubMed ID: 25943718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
    Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
    Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza-induced thrombotic microangiopathy in a patient with cancer on proteasome inhibitor: a diagnostic dilemma.
    Hamad CD; Hoelscher ZC; Tchakarov A; Kala J
    CEN Case Rep; 2022 Aug; 11(3):321-327. PubMed ID: 34997535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival analysis of transplant-associated thrombotic microangiopathy under different diagnostic criteria and the efficacy of plasma exchange.
    Xu Y; Wei Y; Wang L; Lu N; Wu Y; Dou L; Liu D; Li M; Gao C
    Ann Transplant; 2023 Jun; 28():e939890. PubMed ID: 37337423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Secondary thrombotic microangiopathies].
    Coppo P;
    Rev Med Interne; 2017 Nov; 38(11):731-736. PubMed ID: 28890263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant.
    Mulay S; Kreuter JD; Bryant SC; Elliott MA; Hogan WJ; Winters JL; Gastineau DA
    J Clin Apher; 2015 Jun; 30(3):147-53. PubMed ID: 25230249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombotic microangiopathy: new insights.
    Benz K; Amann K
    Curr Opin Nephrol Hypertens; 2010 May; 19(3):242-7. PubMed ID: 20186056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The alternative complement pathway activation product Ba as a marker for transplant-associated thrombotic microangiopathy.
    Sartain S; Shubert S; Wu MF; Wang T; Martinez C
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28070. PubMed ID: 31774252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.
    Elsallabi O; Bhatt VR; Dhakal P; Foster KW; Tendulkar KK
    Clin Appl Thromb Hemost; 2016 Jan; 22(1):12-20. PubMed ID: 26239316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporine-associated thrombotic microangiopathy and thrombocytopenia-associated multiple organ failure: a case successfully treated with therapeutic plasma exchange.
    Ödek Ç; Kendirli T; Yaman A; Ileri T; Kuloğlu Z; Ince E
    J Pediatr Hematol Oncol; 2014 Mar; 36(2):e88-90. PubMed ID: 23619107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange.
    Kennedy GA; Kearey N; Bleakley S; Butler J; Mudie K; Durrant S
    Bone Marrow Transplant; 2010 Apr; 45(4):699-704. PubMed ID: 19767787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic and therapeutic guidelines of thrombotic microangiopathies of the Spanish Apheresis Group].
    Contreras E; de la Rubia J; Del Río-Garma J; Díaz-Ricart M; García-Gala JM; Lozano M;
    Med Clin (Barc); 2015 Apr; 144(7):331.e1-331.e13. PubMed ID: 25433791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic lung adenocarcinoma- associated thrombotic microangiopathy in a renal transplant recipient.
    Vilayur E; de Malmanche J; Trevillian P; Ferreira D
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments.
    Chapin J; Shore T; Forsberg P; Desman G; Van Besien K; Laurence J
    Clin Adv Hematol Oncol; 2014 Sep; 12(9):565-73. PubMed ID: 25654478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients.
    Page EE; Little DJ; Vesely SK; George JN
    Am J Kidney Dis; 2017 Nov; 70(5):686-695. PubMed ID: 28780041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Fatal Case of Thrombotic Microangiopathy Without Schistocytosis and Absent Biochemical Markers of Hemolysis.
    Saha BK; Saha A; Chong W; Beegle S
    Am J Med Sci; 2020 May; 359(5):296-302. PubMed ID: 32265009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation.
    Jodele S; Bleesing JJ; Mehta PA; Filipovich AH; Laskin BL; Goebel J; Pinkard SL; Davies SM
    Pediatr Transplant; 2012 Mar; 16(2):E39-42. PubMed ID: 21054715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced thrombotic microangiopathy: incidence, prevention and management.
    Pisoni R; Ruggenenti P; Remuzzi G
    Drug Saf; 2001; 24(7):491-501. PubMed ID: 11444722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using rheopheresis for stem cell transplantation-associated thrombotic microangiopathy (TA-TMA).
    González-Vicent M; Herrero B; Guillén M; Sevilla J; Díaz MÁ
    Transfus Apher Sci; 2013 Oct; 49(2):234-7. PubMed ID: 23768689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism-mediated thrombotic microangiopathy and B12.
    Goubran H; Ragab G; Sabry W
    Vitam Horm; 2022; 119():441-455. PubMed ID: 35337630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.